Ten30 Bio
↗Alameda, CA, United States
Ten30 Bio is an early-stage biotechnology company focused on developing novel, oral protein-degrading drugs designed to target 'undruggable' proteins. The company leverages advanced peptoid research to create therapeutics capable of crossing the blood-brain barrier, with potential applications in CNS diseases, oncology, and hematology.
Founded by industry veterans, including Dr. Lewis (Rusty) Williams, the company operates as a private, research-driven entity. It is positioned as an emerging player in the drug discovery space, utilizing specialized chemical platforms to engineer powerful drug candidates.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Drug Discovery / Protein Degradation
SIZE & FINANCIALS
Employees:1-50
Founded:2024
Ownership:private
Status:operating
FUNDING
Stage:Seed
Investors:QB3
PIPELINE
Stage:Discovery
Lead Drug Stage:Discovery
Modalities:Small molecule, Peptoid-based therapeutics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Lewis (Rusty) Williams - Executive Chairman and Co-founder
Bill Shelander - Co-founder and COO
Scientific Founders:Lewis (Rusty) Williams
LINKS
Website:ten30bio.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Ten30 Bio and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Ten30 Bio. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.